Saturday 17 October 2026
Export TNON’s income statement to Excel — free account
Tenon Medical, Inc.
TNON Healthcare Medical Devices
Tenon Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 million, up 20.4% from fiscal 2024. In the quarter to June 2026, revenue grew 126.8%, EPS grew 1.88% and free cash flow fell 21.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
2.70
0.21
−7.22%
Follow TNON
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 4 | 5 | 5 |
| (415.74%) | (600.05%) | (558.65%) | 1,475.97% | ||
| (109.47%) | (121.89%) | (94.66%) | (130.22%) | ||
ROIC |
(603.75%) | (622.66%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(307.44%) | (280.71%) | (1,112.54%) | 502.27% | |
Average Days of Receivables |
148.01 | 157.14 | 156.34 | 133.78 | |
Free Cash Flow per Share |
(51.68) | (55.54) | (38.17) | (39.10) | |
Free Cash Flow |
(12.20) | (11.73) | (12.30) | (12.82) | |
Capital Expenditures |
(0.90) | (0.99) | (1.08) | (1.06) | |
| Other line items | |||||
Cash ROIC |
(148.01%) | (133.37%) | (189.19%) | 19,431.82% | |
Accounts Receivable Turnover |
2.96 | 3.08 | 3.22 | 3.91 | |
Accounts Payable Turnover |
1.79 | 2.61 | 2.83 | 2.32 | |
Inventory Turnover |
1.56 | 1.91 | 2.29 | 2.40 | |
Average Days of Payables |
148.23 | 194.47 | 145.82 | 130.02 | |
Days of Inventory on Hand |
323.50 | 242.57 | 181.94 | 162.11 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
67.77% | 54.49% | 46.12% | 44.90% | |
Selling, General and Administrative Expense of Revenue |
389.79% | 329.64% | 288.34% | 264.61% | |
Share Based Compensation of Revenue |
68.98% | 42.88% | 25.02% | 21.55% | |
Interest Coverage |
— | — | (53.66) | (11.95) | |
Operating CF/Net income |
0.88 | 0.86 | 0.90 | 0.86 | |
Depreciation/Fixed assets |
0.83 | 0.58 | 0.83 | 2.10 | |
Capex/Depreciation |
(1.64) | (1.86) | (1.43) | (0.65) | |
Revenue per Share |
13.70 | 18.67 | 14.26 | 16.20 | |
Operating CF per Share |
(47.87) | (50.88) | (34.82) | (35.87) | |
Capex per Share |
(3.81) | (4.67) | (3.35) | (3.23) | |
Capex to Sales |
0.28 | 0.25 | 0.23 | 0.20 |
Columns are period end dates